| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 851.20M | 1.53B | 1.63B | 1.78B | 1.29B |
| Gross Profit | 247.30M | 754.00M | 790.80M | 1.09B | 646.50M |
| EBITDA | 628.60M | 1.11B | 860.20M | 1.20B | 930.80M |
| Net Income | 6.50M | 54.60M | -109.60M | 49.10M | -80.70M |
Balance Sheet | |||||
| Total Assets | 3.28B | 4.05B | 4.46B | 5.04B | 5.54B |
| Cash, Cash Equivalents and Short-Term Investments | 329.20M | 548.60M | 499.00M | 636.30M | 469.10M |
| Total Debt | 2.26B | 2.71B | 2.99B | 3.46B | 3.73B |
| Total Liabilities | 3.53B | 4.32B | 4.82B | 5.50B | 6.01B |
| Stockholders Equity | -252.90M | -272.70M | -359.40M | -459.50M | -466.10M |
Cash Flow | |||||
| Free Cash Flow | 138.70M | 534.00M | 583.70M | 771.40M | 550.40M |
| Operating Cash Flow | 334.30M | 758.50M | 876.20M | 1.08B | 786.90M |
| Investing Cash Flow | 149.50M | -213.10M | -268.50M | -356.20M | -101.70M |
| Financing Cash Flow | -700.20M | -492.20M | -742.50M | -552.80M | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £119.64M | -7.76 | 1.89% | 6.46% | -18.06% | -127.50% | |
71 Outperform | £221.45M | 1.81 | 5.30% | ― | -11.74% | ― | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
53 Neutral | £164.87M | -38.48 | -0.15% | ― | -38.66% | -105.45% | |
52 Neutral | £246.51M | 18.32 | -2.23% | ― | -47.84% | -277.39% | |
50 Neutral | £140.42M | -5.79 | -11.54% | ― | -10.76% | 88.89% | |
44 Neutral | £164.49M | 2.37 | 53.68% | ― | 4.56% | ― |